# US 2016/0354433 A1 · Genetically modified microorganisms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354433 A1
- Document ID: US20160354433A1
- Status: Published application
- Kind: A1
- Application number: 14/757,730
- Filed: 2015-12-23
- Published: 2016-12-08
- Earliest claimed: 2013-11-29
- Assignees: Myos Corp.
- Applicants: MYOS Corporation
- Inventors: Robert J. Hariri
- Web page: https://patentgrep.com/patent/US20160354433A1

## CPC

- A61K 38/1703: {from vertebrates}
- A23L 33/14: Yeasts or derivatives thereof
- A23L 33/17: Amino acids, peptides or proteins
- A23L 33/195: Proteins from microorganisms
- C07K 14/4703: {Inhibitors; Suppressors}
- C07K 14/495: Transforming growth factor [TGF]
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2200/316: having an effect on regeneration or building of ligaments or muscles
- C12C 2200/05: Use of genetically modified microorganisms in the preparation of beer
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C12C: BEER; PREPARATION OF BEER BY FERMENTATION (ageing or ripening by storing C12H1/22; methods for reducing the alcohol content after fermentation C12H3/00; methods for increasing the alcohol content after fermentation C12H6/00; venting devices for casks, barrels or the like C12L9/00); PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER

## Abstract

Embodiments of the present invention are generally related to genetically modified microorganisms. More specifically, embodiments of the present invention relate to genetically modified microorganisms having the avian follistatin genome engineered therein to create a microorganism strain having the enhanced properties of follistatin. In accordance with one embodiment of the present invention, a method of treating an individual with a muscle degenerative disease comprises administering an effective amount of avian follistatin, wherein the avian follistatin is derived from a genetically modified microorganism.

## Claims

### Claim 1

A method of treating an individual with a muscle degenerative disease comprising: administering an effective amount of avian follistatin, wherein the avian follistatin is derived from a genetically modified microorganism.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of administering the effective amount of avian follistatin comprises providing for consumption, at least one of a food product or a fermented beverage product.

### Claim 3 (depends on 2)

The method of claim 2, wherein the food product comprises one of bread, pastry or baked goods.

### Claim 4 (depends on 2)

The method of claim 2, wherein the fermented beverage product comprises one of wine, beer or liquor.
